Overview and Implications: The Food And Drug Administration's Proposal to Permit Generic Drug Manufacturers to Initiate Labeling Changes

This site uses cookies to enhance functionality and performance. You may change your cookie settings at any time. If you do nothing, you are giving implied consent to the use of cookies on this website.